TWO SIGMA INVESTMENTS, LP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 93 filers reported holding SEELOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$76,000
-77.2%
73,499
-85.0%
0.00%
-100.0%
Q2 2022$333,000
-60.5%
489,972
-51.4%
0.00%
-50.0%
Q1 2022$844,000
-58.6%
1,007,789
-19.4%
0.00%
-50.0%
Q4 2021$2,038,000
-13.6%
1,250,384
+27.7%
0.00%
-20.0%
Q3 2021$2,360,000
-50.4%
979,349
-45.7%
0.01%
-54.5%
Q2 2021$4,760,0001,803,1410.01%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders